Erbitux and dyspnoea Patient Reports February 10, 2010

Erbitux Side Effects Report #5040854-1
Erbitux side effect was reported by a Consumer or non-health professional from UNITED STATES on June 26, 2006. Male patient, 53 years of age, weighting 154.3 lb, was diagnosed with tonsil cancer and was treated with Erbitux. After drug was administered, patient experienced the following side effects: coma, dyspnoea. Erbitux dosage: unknown. During the same period patient was treated with DECADRON, BENADRYL, TYLENOL, PREDNISONE, INHALERS, TOPROL. Patient was hospitalized. Patient recovered.

Erbitux Side Effects Report #5082576-7
Erbitux side effect was reported by a Consumer or non-health professional from UNITED STATES on June 26, 2006. Male patient, 53 years of age, weighting 154.3 lb, was diagnosed with tonsil cancer and was treated with Erbitux. After drug was administered, patient experienced the following side effects: coma, dyspnoea, malignant neoplasm progression. Erbitux dosage: unknown. During the same period patient was treated with DECADRON, BENADRYL, ACETAMINOPHEN, PREDNISONE, INHALERS, TOPROL. Patient was hospitalized. Patient died on 07/22/2006.

Erbitux Side Effects Report #4886254-6
Erbitux side effect was reported by a Health Professional from UNITED STATES on Jan 18, 2006. Female patient, 52 years of age, weighting 166.0 lb, was diagnosed with tonsil cancer and was treated with Erbitux. After drug was administered, patient experienced the following side effects: condition aggravated, cough, dyspnoea, leukopenia, neck mass, necrosis, neutropenia, pain , rash . Erbitux dosage: unknown. During the same period patient was treated with CARBOPLATIN, PACLITXAEL. Patient was hospitalized. Patient recovered.

Erbitux Side Effects Report #4657635-0
Erbitux side effect was reported by a Consumer or non-health professional from on May 03, 2005. Male patient, 38 years of age, was diagnosed with tonsil cancer and was treated with Erbitux. After drug was administered, patient experienced the following side effects: abdominal pain , dyspnoea, flushing, muscle spasms. Erbitux dosage: unknown. Patient recovered.


Erbitux Side Effects Report #4729945-X
Erbitux side effect was reported by a Consumer or non-health professional from UNITED STATES on May 03, 2005. Male patient, 38 years of age, was diagnosed with tonsil cancer and was treated with Erbitux. After drug was administered, patient experienced the following side effects: abdominal pain , dyspnoea, flushing, muscle spasms, oedema, oxygen saturation abnormal. Erbitux dosage: 788 MG.. During the same period patient was treated with CISPLATIN, DEXAMETHASONE, DIPHENHYDRAMINE, EMEND, FAMOTIDINE, GRANISETRON, HYDROCORTISONE. Patient recovered.

Erbitux Side Effects Report #5684623-8
Erbitux side effect was reported by a Consumer or non-health professional from UNITED STATES on Apr 17, 2007. Female patient, 80 years of age, weighting 99.21 lb, was diagnosed with squamous cell carcinoma and was treated with Erbitux. After drug was administered, patient experienced the following side effects: dyspnoea, infusion related reaction, wheezing. Erbitux dosage: unknown. During the same period patient was treated with BENADRYL, ISOSORBIDE MONONITRATE, TOPROL, FAMOTIDINE. Patient recovered.

Erbitux Side Effects Report #5082676-1
Erbitux side effect was reported by a Health Professional from UNITED STATES on Aug 14, 2006. Male patient, 64 years of age, weighting 202.8 lb, was diagnosed with squamous cell carcinoma and was treated with Erbitux. After drug was administered, patient experienced the following side effects: anaemia, dyspnoea, febrile neutropenia, mucosal inflammation, platelet count decreased, pyrexia, renal failure, white blood cell count decreased. Erbitux dosage: unknown. During the same period patient was treated with CISPLATIN, CIPROFLOXACIN, CLAVULIN. Patient was hospitalized. Patient recovered.

Erbitux Side Effects Report #5684577-4
Erbitux side effect was reported by a Consumer or non-health professional from UNITED STATES on Mar 07, 2007. Male patient, 62 years of age, was diagnosed with squamous cell carcinoma and was treated with Erbitux. After drug was administered, patient experienced the following side effects: blood pressure decreased, burning sensation, cold sweat, dyspnoea, hyperhidrosis, oxygen saturation decreased. Erbitux dosage: unknown. During the same period patient was treated with BENADRYL. Patient recovered.

Erbitux Side Effects Report #5040843-7
Erbitux side effect was reported by a Consumer or non-health professional from UNITED STATES on May 26, 2006. Male patient, 56 years of age, weighting 112.4 lb, was diagnosed with squamous cell carcinoma and was treated with Erbitux. After drug was administered, patient experienced the following side effects: blood creatinine increased, dyspnoea, haemoglobin decreased, hypocalcaemia, hypotension, hypoxia, infection , neutropenia, neutrophil count decreased. Erbitux dosage: INITIATED ON 04-APR-2006 AT 400 MG/M2 F/B 250 MG/M2 WEEKLY X 9 WEEKS/TOTL DOSE THIS COURSE = 400 MG.. During the same period patient was treated with CISPLATIN. Patient was hospitalized. Patient died on 06/15/2006.


Erbitux Side Effects Report #5014462-2
Erbitux side effect was reported by a Consumer or non-health professional from UNITED STATES on May 26, 2006. Male patient, 56 years of age, weighting 112.4 lb, was diagnosed with squamous cell carcinoma and was treated with Erbitux. After drug was administered, patient experienced the following side effects: dyspnoea, haemoglobin decreased, hypocalcaemia, hypotension, hypoxia, infection , neutrophil count decreased, white blood cell count decreased. Erbitux dosage: INITIATED ON 04-APR-2006 AT 400 MG/M2 F/B 250 MG/M2 WEEKLY X 9 WEEKS/TOTL DOSE THIS COURSE = 400 MG.. During the same period patient was treated with CISPLATIN. Patient was hospitalized. Patient recovered.

Erbitux Side Effects Report #5039388-X
Erbitux side effect was reported by a Consumer or non-health professional from UNITED STATES on May 26, 2006. Male patient, 56 years of age, weighting 112.4 lb, was diagnosed with squamous cell carcinoma and was treated with Erbitux. After drug was administered, patient experienced the following side effects: blood creatinine increased, dyspnoea, haemoglobin decreased, hypocalcaemia, hypotension, hypoxia, infection , neutrophil count decreased, platelet count decreased. Erbitux dosage: INITIATED ON 04-APR-2006 AT 400 MG/M2 F/B 250 MG/M2 WEEKLY X 9 WEEKS/TOTL DOSE THIS COURSE = 400 MG.. During the same period patient was treated with CISPLATIN. Patient was hospitalized. Patient died on 06/15/2006.

Erbitux Side Effects Report #5684891-2
Erbitux side effect was reported by a Health Professional from UNITED STATES on Dec 05, 2007. Male patient, 48 years of age, was diagnosed with squamous cell carcinoma and was treated with Erbitux. After drug was administered, patient experienced the following side effects: dyspnoea, hypoaesthesia oral, infusion related reaction, periorbital oedema, rash . Erbitux dosage: 6/13/07STPD-49MIN10/17/07-800MGIV,STPD@200CC,AFTER30MIN@50CC/HR 15MIN100 CC/HR 15M, 200CC/HR.. During the same period patient was treated with CARBOPLATIN, FLUOROURACIL, DECADRON, BENADRYL. Patient was hospitalized. Patient recovered.

Erbitux Side Effects Report #5711582-1
Erbitux side effect was reported by a Physician from UNITED STATES on Apr 16, 2008. Male patient, 32 years of age, weighting 180.8 lb, was diagnosed with squamous cell carcinoma and was treated with Erbitux. After drug was administered, patient experienced the following side effects: anoxic encephalopathy, dyspnoea, syncope. Erbitux dosage: unknown. During the same period patient was treated with FENTANYL CITRATE, METHADONE. Patient was hospitalized. Patient died on 04/07/2008.

Erbitux Side Effects Report #5841763-8
Erbitux side effect was reported by a Pharmacist from UNITED STATES on Aug 11, 2008. Male patient, 69 years of age, weighting 163.0 lb, was diagnosed with recurrent cancer, squamous cell carcinoma and was treated with Erbitux. After drug was administered, patient experienced the following side effects: cardio-respiratory arrest, dyspnoea, feeling hot, foaming at mouth, infusion related reaction. Erbitux dosage: 400MG/M2 = 750 MG DOSE ONE TIME IV. Patient was hospitalized. Patient recovered.


Erbitux Side Effects Report #4944404-7
Erbitux side effect was reported by a Consumer or non-health professional from UNITED STATES on Oct 20, 2005. Male patient, 82 years of age, was diagnosed with rectal cancer stage iv and was treated with Erbitux. After drug was administered, patient experienced the following side effects: blood pressure immeasurable, coma, dyspnoea, lethargy, oxygen saturation immeasurable, pulse abnormal. Erbitux dosage: unknown. During the same period patient was treated with CIMETIDINE, DIPHENHYDRAMINE. Patient was hospitalized. Patient recovered.

Erbitux Side Effects Report #5012753-2
Erbitux side effect was reported by a Health Professional from UNITED STATES on Jan 24, 2006. Female patient, 49 years of age, was diagnosed with rectal cancer metastatic and was treated with Erbitux. After drug was administered, patient experienced the following side effects: chills, dyspnoea, muscle spasms, tachycardia. Erbitux dosage: unknown. During the same period patient was treated with AVASTIN. Patient recovered.

Erbitux Side Effects Report #4696804-0
Erbitux side effect was reported by a Consumer or non-health professional from on June 15, 2005. Male patient, 46 years of age, weighting 187.4 lb, was diagnosed with rectal cancer metastatic and was treated with Erbitux. After drug was administered, patient experienced the following side effects: dyspnoea, myocardial infarction, nausea . Erbitux dosage: unknown. During the same period patient was treated with BENADRYL, IRINOTECAN, COUMADIN, POTASSIUM CHLORIDE, ATENOLOL, LOMOTIL, VICODIN. Patient was hospitalized. Patient recovered.

Erbitux Side Effects Report #5684862-6
Erbitux side effect was reported by a Consumer or non-health professional from UNITED STATES on Oct 31, 2007. Male patient, 78 years of age, was diagnosed with rectal cancer and was treated with Erbitux. After drug was administered, patient experienced the following side effects: dyspnoea, wheezing. Erbitux dosage: unknown. Patient recovered.

Erbitux Side Effects Report #6131381-9
Erbitux side effect was reported by a Consumer or non-health professional from UNITED STATES on June 17, 2008. Female patient, 70 years of age, was diagnosed with rectal cancer and was treated with Erbitux. After drug was administered, patient experienced the following side effects: anxiety , dyspnoea, erythema, swelling face. Erbitux dosage: unknown. During the same period patient was treated with ZANTAC, BENADRYL, DEXAMETHASONE. Patient recovered.


Erbitux Side Effects Report #4747997-8
Erbitux side effect was reported by a Consumer or non-health professional from UNITED STATES on Aug 11, 2005. Female patient, 54 years of age, weighting 12361 lb, was diagnosed with rectal cancer and was treated with Erbitux. After drug was administered, patient experienced the following side effects: chest discomfort, dyspnoea. Erbitux dosage: FIRST DOSE ADMINISTERED (648 MG) ON 03-AUG-2005. SECOND DOSE ON 10-AUG-2005 51 CC (114 MG).. During the same period patient was treated with BENADRYL. Patient recovered.

Erbitux Side Effects Report #4767622-X
Erbitux side effect was reported by a Consumer or non-health professional from UNITED STATES on Aug 11, 2005. Female patient, 54 years of age, weighting 12361 lb, was diagnosed with rectal cancer and was treated with Erbitux. After drug was administered, patient experienced the following side effects: chest discomfort, dyspnoea, skin discolouration. Erbitux dosage: FIRST DOSE ADMINISTERED (648 MG) ON 03-AUG-2005. SECOND DOSE ON 10-AUG-2005 51 CC (114 MG).. During the same period patient was treated with OXALIPLATIN, LEUCOVORIN, FLUOROURACIL, BENADRYL, ALOXI, ATIVAN, DECADRON, CALCIUM GLUCONATE. Patient recovered.

Erbitux Side Effects Report #5434534-8
Erbitux side effect was reported by a Consumer or non-health professional from UNITED STATES on Aug 28, 2007. Male patient was diagnosed with pancreatic carcinoma and was treated with Erbitux. After drug was administered, patient experienced the following side effects: chest pain , dyspnoea, hypotension. Erbitux dosage: unknown. Patient recovered.

Erbitux Side Effects Report #4604365-7
Erbitux side effect was reported by a Health Professional from on Mar 09, 2005. Female patient, 71 years of age, weighting 158.7 lb, was diagnosed with ovarian cancer and was treated with Erbitux. After drug was administered, patient experienced the following side effects: back pain , blood creatine phosphokinase increased, blood creatine phosphokinase mb increased, blood pressure increased, dyspnoea, myocardial infarction, oxygen saturation decreased, respiratory rate increased, transfusion reaction. Erbitux dosage: 250 MG/M2 Q WEEK IV. Patient was hospitalized. Patient recovered.

Erbitux Side Effects Report #5684584-1
Erbitux side effect was reported by a Consumer or non-health professional from UNITED STATES on May 08, 2007. Male patient, 79 years of age, was diagnosed with oesophageal carcinoma and was treated with Erbitux. After drug was administered, patient experienced the following side effects: chills, dyspnoea, infusion related reaction. Erbitux dosage: unknown. During the same period patient was treated with BENADRYL. Patient recovered.


Erbitux Side Effects Report #4973451-4
Erbitux side effect was reported by a Health Professional from UNITED STATES on Apr 13, 2006. Male patient, 64 years of age, weighting 128.0 lb, was diagnosed with oesophageal carcinoma and was treated with Erbitux. After drug was administered, patient experienced the following side effects: cardio-respiratory arrest, cough, dyspnoea. Erbitux dosage: unknown. During the same period patient was treated with DECADRON, BENADRYL, TYLENOL. Patient was hospitalized. Patient recovered.

Erbitux Side Effects Report #4988420-8
Erbitux side effect was reported by a Health Professional from UNITED STATES on Apr 26, 2006. Male patient, 64 years of age, was diagnosed with oesophageal carcinoma and was treated with Erbitux. After drug was administered, patient experienced the following side effects: blood creatinine increased, dehydration, dyspnoea. Erbitux dosage: INITIATED ON 14-FEB-2006 AT 400 MG/M2/TOTAL DOSE 2820 MG.. During the same period patient was treated with CARBOPLATIN, PACLITAXEL. Patient was hospitalized. Patient recovered.

Erbitux Side Effects Report #5004548-0
Erbitux side effect was reported by a Health Professional from UNITED STATES on Apr 26, 2006. Male patient, 64 years of age, was diagnosed with oesophageal carcinoma and was treated with Erbitux. After drug was administered, patient experienced the following side effects: blood creatinine increased, dehydration, dyspnoea. Erbitux dosage: INITIATED ON 14-FEB-2006 AT 400 MG/M2/TOTAL DOSE 2820 MG.. During the same period patient was treated with CARBOPLATIN, PACLITAXEL. Patient was hospitalized. Patient recovered.

Erbitux Side Effects Report #5091764-5
Erbitux side effect was reported by a Consumer or non-health professional from UNITED STATES on May 11, 2006. Male patient, 55 years of age, was diagnosed with oesophageal carcinoma and was treated with Erbitux. After drug was administered, patient experienced the following side effects: dyspnoea, hypotension, nausea . Erbitux dosage: unknown. During the same period patient was treated with ATIVAN, BENADRYL, CISPLATIN, LISINOPRIL, NEULASTA, PREVACID, TAXOTERE. Patient recovered.

Erbitux Side Effects Report #6131362-5
Erbitux side effect was reported by a Consumer or non-health professional from UNITED STATES on June 27, 2008. Male patient, 62 years of age, was diagnosed with oesophageal adenocarcinoma and was treated with Erbitux. After drug was administered, patient experienced the following side effects: dyspnoea, erythema. Erbitux dosage: unknown. During the same period patient was treated with IRINOTECAN, TAXOTERE. Patient recovered.


Erbitux Side Effects Report #5061945-5
Erbitux side effect was reported by a Health Professional from UNITED STATES on Apr 25, 2006. Male patient, 57 years of age, weighting 169.8 lb, was diagnosed with non-small cell lung cancer metastatic, hyperlipidaemia, gastrooesophageal reflux disease, insomnia and was treated with Erbitux. After drug was administered, patient experienced the following side effects: atrial fibrillation , confusional state, dyspnoea, malignant neoplasm progression. Erbitux dosage: unknown. During the same period patient was treated with PEMETREXED DI, PLAVIX, CARAFATE, RESTORIL, DEXAMETHASONE, ALBUTEROL SPIROS. Patient was hospitalized. Patient recovered.

Erbitux Side Effects Report #4816095-7
Erbitux side effect was reported by a Consumer or non-health professional from UNITED STATES on Aug 16, 2005. Female patient, 84 years of age, weighting 180.8 lb, was diagnosed with non-small cell lung cancer and was treated with Erbitux. After drug was administered, patient experienced the following side effects: chest discomfort, chills, dyspnoea, eye irritation, muscle tightness, nasal discomfort. Erbitux dosage: unknown. During the same period patient was treated with DECADRON, BENADRYL. Patient was hospitalized. Patient recovered.

Erbitux Side Effects Report #4967402-6
Erbitux side effect was reported by a Consumer or non-health professional from UNITED STATES on Feb 24, 2005. Female patient, 80 years of age, was diagnosed with non-small cell lung cancer and was treated with Erbitux. After drug was administered, patient experienced the following side effects: dyspnoea, hypoxia, respiratory failure. Erbitux dosage: unknown. During the same period patient was treated with CARBOPLATIN, PACLITAXEL, COUMADIN, PROTONIX, REGLAN, NOVOLIN N, HUMALOG, FORADIL. Patient was hospitalized. Patient recovered.

Erbitux Side Effects Report #5671294-X
Erbitux side effect was reported by a Health Professional from UNITED STATES on Mar 14, 2008. Male patient, 71 years of age, weighting 158.7 lb, was diagnosed with non-small cell lung cancer and was treated with Erbitux. After drug was administered, patient experienced the following side effects: chills, dyspnoea, neutropenia, pyrexia. Erbitux dosage: unknown. During the same period patient was treated with TAXOL, CARBOPLATIN, THEOPHYLLINE, HYDROXYZINE, SPIRIVA, ADVAIR DISKUS, SAW PALMETTO. Patient was hospitalized. Patient recovered.

Erbitux Side Effects Report #5061948-0
Erbitux side effect was reported by a Consumer or non-health professional from UNITED STATES on July 19, 2006. Male patient, 69 years of age, was diagnosed with non-small cell lung cancer and was treated with Erbitux. After drug was administered, patient experienced the following side effects: dyspnoea. Erbitux dosage: unknown. During the same period patient was treated with TAXOL, CARBOPLATIN, METFORMIN, ASPIRIN, PEPCID AC. Patient was hospitalized. Patient recovered.


Erbitux Side Effects Report #5074127-8
Erbitux side effect was reported by a Consumer or non-health professional from UNITED STATES on July 19, 2006. Male patient, 69 years of age, was diagnosed with non-small cell lung cancer and was treated with Erbitux. After drug was administered, patient experienced the following side effects: dyspnoea. Erbitux dosage: unknown. During the same period patient was treated with TAXOL, CARBOPLATIN, METFORMIN, ASPIRIN, PEPCID AC. Patient was hospitalized. Patient recovered.

Erbitux Side Effects Report #5529307-1
Erbitux side effect was reported by a Consumer or non-health professional from UNITED STATES on Nov 20, 2007. Female patient, 68 years of age, weighting 130.1 lb, was diagnosed with non-small cell lung cancer and was treated with Erbitux. After drug was administered, patient experienced the following side effects: anorexia, diastolic dysfunction, dyspnoea, fatigue, hypoxia, left ventricular dysfunction, pulmonary oedema, sinus tachycardia. Erbitux dosage: unknown. During the same period patient was treated with PACLITAXEL, CARBOPLATIN, BEVACIZUMAB, COREG, LASIX. Patient was hospitalized. Patient recovered.

Erbitux Side Effects Report #4663407-3
Erbitux side effect was reported by a Health Professional from on May 10, 2005. Female patient, 68 years of age, was diagnosed with non-small cell lung cancer and was treated with Erbitux. After drug was administered, patient experienced the following side effects: blood pressure systolic increased, cardiac murmur, dyspnoea, electrocardiogram st-t change, flushing, hyperhidrosis, hypoxia, respiratory rate increased, sinus tachycardia. Erbitux dosage: FIRST CYCLE (DOSE 380 MG), STOPPED.. During the same period patient was treated with CARBOPLATIN, GEMZAR, BENADRYL, CIPRO, DUONEB, CLARITIN, PERCOCET, PROTONIX. Patient was hospitalized. Patient recovered.

Erbitux Side Effects Report #4716681-9
Erbitux side effect was reported by a Health Professional from UNITED STATES on May 10, 2005. Female patient, 68 years of age, was diagnosed with non-small cell lung cancer and was treated with Erbitux. After drug was administered, patient experienced the following side effects: bronchitis , deep vein thrombosis , dyspnoea, flushing, hyperhidrosis, wheezing. Erbitux dosage: FIRST CYCLE (DOSE 380 MG), STOPPED.. During the same period patient was treated with CARBOPLATIN, GEMZAR, BENADRYL, CIPRO, DUONEB, CLARITIN, PERCOCET, PROTONIX. Patient was hospitalized. Patient recovered.

Erbitux Side Effects Report #4724502-3
Erbitux side effect was reported by a Health Professional from UNITED STATES on May 10, 2005. Female patient, 68 years of age, was diagnosed with non-small cell lung cancer and was treated with Erbitux. After drug was administered, patient experienced the following side effects: dyspnoea, infusion related reaction. Erbitux dosage: FIRST CYCLE (DOSE 380 MG), STOPPED.. During the same period patient was treated with CARBOPLATIN, GEMZAR, BENADRYL, CIPRO, DUONEB, CLARITIN, PERCOCET, PROTONIX. Patient was hospitalized. Patient recovered.


Erbitux Side Effects Report #4731276-9
Erbitux side effect was reported by a Health Professional from UNITED STATES on May 10, 2005. Female patient, 68 years of age, was diagnosed with non-small cell lung cancer and was treated with Erbitux. After drug was administered, patient experienced the following side effects: dyspnoea. Erbitux dosage: FIRST CYCLE (DOSE 380 MG), STOPPED.. During the same period patient was treated with CARBOPLATIN, GEMZAR, BENADRYL, CIPRO, DUONEB, CLARITIN, PERCOCET, PROTONIX. Patient was hospitalized. Patient recovered.

Erbitux Side Effects Report #5056383-5
Erbitux side effect was reported by a Health Professional from UNITED STATES on July 14, 2006. Female patient, 66 years of age, weighting 154.3 lb, was diagnosed with non-small cell lung cancer and was treated with Erbitux. After drug was administered, patient experienced the following side effects: dyspnoea, erythema, pruritus, throat irritation, urticaria. Erbitux dosage: unknown. Patient recovered.

Erbitux Side Effects Report #5060016-1
Erbitux side effect was reported by a Health Professional from UNITED STATES on July 17, 2006. Male patient, 65 years of age, was diagnosed with non-small cell lung cancer and was treated with Erbitux. After drug was administered, patient experienced the following side effects: dyspnoea. Erbitux dosage: unknown. During the same period patient was treated with PACLITAXEL, CARBOPLATIN, ASPIRIN, CANDESARTAN CILEXETIL, FUROSEMIDE, ATORVASTATIN CALCIUM, HYDROCODONE BITARTRATE, ALBUTEROL SULPHATE. Patient was hospitalized. Patient recovered.

Erbitux Side Effects Report #5099936-0
Erbitux side effect was reported by a Health Professional from UNITED STATES on July 17, 2006. Male patient, 65 years of age, was diagnosed with non-small cell lung cancer and was treated with Erbitux. After drug was administered, patient experienced the following side effects: anaemia, dyspnoea, granulocytopenia, homans' sign, lung infection, neuropathy. Erbitux dosage: unknown. During the same period patient was treated with CARBOPLATIN, PACLITAXEL, ASPIRIN, CANDESARTAN CILEXETIL, FUROSEMIDE, ATORVASTATIN CALCIUM, HYDROCODONE BITARTRATE, ALBUTEROL SULPHATE. Patient was hospitalized. Patient recovered.

Erbitux Side Effects Report #4991865-3
Erbitux side effect was reported by a Health Professional from UNITED STATES on Apr 27, 2006. Female patient, 65 years of age, was diagnosed with non-small cell lung cancer and was treated with Erbitux. After drug was administered, patient experienced the following side effects: dyspnoea. Erbitux dosage: unknown. During the same period patient was treated with CARBOPLATIN, PACLITAXEL, DARVOCET, LEVAQUIN. Patient was hospitalized. Patient recovered.

Erbitux Side Effects Report #5063088-3
Erbitux side effect was reported by a Consumer or non-health professional from IRELAND on Aug 01, 2005. Male patient, 63 years of age, was diagnosed with non-small cell lung cancer and was treated with Erbitux. After drug was administered, patient experienced the following side effects: dyspnoea, febrile bone marrow aplasia. Erbitux dosage: unknown. During the same period patient was treated with CISPLATIN, VINORELBINE. Patient was hospitalized. Patient died on 08/04/2005.

Erbitux Side Effects Report #4992478-X
Erbitux side effect was reported by a Health Professional from GERMANY on Aug 01, 2005. Male patient, 63 years of age, was diagnosed with non-small cell lung cancer and was treated with Erbitux. After drug was administered, patient experienced the following side effects: dyspnoea, febrile bone marrow aplasia. Erbitux dosage: unknown. During the same period patient was treated with CISPLATIN, VINORELBINE. Patient was hospitalized. Patient died on 08/04/2005.

Erbitux Side Effects Report #4967896-6
Erbitux side effect was reported by a Health Professional from UNITED STATES on Apr 07, 2006. Male patient, 62 years of age, weighting 227.1 lb, was diagnosed with non-small cell lung cancer and was treated with Erbitux. After drug was administered, patient experienced the following side effects: dyspnoea, hyperhidrosis, hypotension, infusion related reaction, oxygen saturation decreased. Erbitux dosage: 400 MG/M2, IV. Patient recovered.

Erbitux Side Effects Report #5118448-9
Erbitux side effect was reported by a Physician from GERMANY on Sept 15, 2006. Male patient, 56 years of age, was diagnosed with non-small cell lung cancer and was treated with Erbitux. After drug was administered, patient experienced the following side effects: dyspnoea. Erbitux dosage: unknown. During the same period patient was treated with CARBOPLATIN, GEMCITABINE. Patient was hospitalized. Patient recovered.

Erbitux Side Effects Report #5011977-8
Erbitux side effect was reported by a Health Professional from UNITED STATES on May 11, 2006. Male patient, 56 years of age, weighting 138.9 lb, was diagnosed with non-small cell lung cancer and was treated with Erbitux. After drug was administered, patient experienced the following side effects: dyspnoea, haemoptysis, hypoxia, metastases to lymph nodes, pneumonitis, respiratory failure. Erbitux dosage: unknown. During the same period patient was treated with DOCETAXEL, ELAVIL, AMITRIPTYLINE, PREDNISONE, MORPHINE, LEVAQUIN, LEXAPRO, PRAZEPAM. Patient was hospitalized. Patient died on 04/30/2006.


Erbitux Side Effects Report #5252518-X
Erbitux side effect was reported by a Physician from UNITED STATES on Jan 24, 2007. Male patient, 54 years of age, was diagnosed with non-small cell lung cancer and was treated with Erbitux. After drug was administered, patient experienced the following side effects: anxiety , cyanosis, dyspnoea, flushing. Erbitux dosage: unknown. During the same period patient was treated with BENADRYL, TYLENOL. Patient recovered.

Erbitux Side Effects Report #4979255-0
Erbitux side effect was reported by a Consumer or non-health professional from GERMANY on Apr 11, 2006. Male patient, 53 years of age, was diagnosed with non-small cell lung cancer and was treated with Erbitux. After drug was administered, patient experienced the following side effects: dyspnoea. Erbitux dosage: unknown. During the same period patient was treated with CISPLATIN, VINORELBINE. Patient was hospitalized. Patient recovered.

Erbitux Side Effects Report #5252510-5
Erbitux side effect was reported by a Consumer or non-health professional from UNITED STATES on Jan 12, 2007. Female patient, weighting 114.6 lb, was diagnosed with non-small cell lung cancer and was treated with Erbitux. After drug was administered, patient experienced the following side effects: asthenia, constipation , dyspnoea, ear pain, rash pustular, skin exfoliation, stomatitis, weight decreased. Erbitux dosage: unknown. During the same period patient was treated with CISPLATIN, EFFEXOR, DARVOCET, IBUPROFEN, DUONEB, NEULASTA. Patient recovered.

Erbitux Side Effects Report #5586854-4
Erbitux side effect was reported by a Health Professional from UNITED STATES on Mar 14, 2007. Female patient, weighting 114.6 lb, was diagnosed with non-small cell lung cancer and was treated with Erbitux. After drug was administered, patient experienced the following side effects: asthenia, constipation , dyspnoea, ear pain, rash pustular, skin exfoliation, stomatitis, weight decreased. Erbitux dosage: unknown. During the same period patient was treated with CISPLATIN, EFFEXOR, DARVOCET, IBUPROFEN, DUONEB, NEULASTA, MAGNESIUM SULPHATE, BENADRYL. Patient recovered.

Erbitux Side Effects Report #4642116-0
Erbitux side effect was reported by a Health Professional from on Apr 21, 2005. Female patient, weighting 160.0 lb, was diagnosed with non-small cell lung cancer and was treated with Erbitux. After drug was administered, patient experienced the following side effects: blood pressure decreased, chest discomfort, chest pain , dyspnoea, pulse pressure decreased. Erbitux dosage: 440MG IV Q WEEK. During the same period patient was treated with TAXOL, CARBOPLATIN, ZOLOFT, NEXIUM, MOBIC, POTASSIUM CHLORIDE, GLUCOPHAGE. Patient was hospitalized. Patient recovered.

Erbitux Side Effects Report #4675704-6
Erbitux side effect was reported by a Physician from on Feb 08, 2005. Male patient was diagnosed with non-small cell lung cancer and was treated with Erbitux. After drug was administered, patient experienced the following side effects: blood pressure decreased, dyspnoea. Erbitux dosage: 400 MG PER LITER SQUARED.. Patient recovered.

Erbitux Side Effects Report #5307115-4
Erbitux side effect was reported by a Physician from UNITED STATES on Apr 23, 2007. Male patient, weighting 244.0 lb, was diagnosed with neoplasm recurrence, rectal cancer metastatic and was treated with Erbitux. After drug was administered, patient experienced the following side effects: acidosis, cardiac arrest , dyspnoea, feeling hot, infusion related reaction, myocardial infarction, respiratory arrest, ventricular tachycardia. Erbitux dosage: 888 MG INITIAL DOSE IV. Patient died on 04/17/2007.

Erbitux Side Effects Report #5684641-X
Erbitux side effect was reported by a Health Professional from GERMANY on May 24, 2007. Male patient, 83 years of age, was diagnosed with neoplasm malignant and was treated with Erbitux. After drug was administered, patient experienced the following side effects: blood pressure increased, dyspnoea, heart rate increased, hypersensitivity. Erbitux dosage: unknown. During the same period patient was treated with ZANTAC, BENADRYL. Patient recovered.

Erbitux Side Effects Report #5684575-0
Erbitux side effect was reported by a Consumer or non-health professional from UNITED STATES on Sept 19, 2007. Female patient, 77 years of age, weighting 149.9 lb, was diagnosed with neoplasm malignant and was treated with Erbitux. After drug was administered, patient experienced the following side effects: dyspnoea, nausea , pyrexia, skin disorder, skin swelling, throat tightness. Erbitux dosage: unknown. During the same period patient was treated with BENADRYL, OMEPRAZOLE, NASONEX, XANAX. Patient was hospitalized. Patient recovered.

Erbitux Side Effects Report #5684836-5
Erbitux side effect was reported by a Consumer or non-health professional from UNITED STATES on Nov 16, 2007. Male patient, 77 years of age, was diagnosed with neoplasm malignant and was treated with Erbitux. After drug was administered, patient experienced the following side effects: bronchospasm, dyspnoea, hypotension, loss of consciousness, urticaria. Erbitux dosage: 100 MG TEST DOSE (28 MINUTES INTO TEST DOSE). During the same period patient was treated with BENADRYL, TYLENOL. Patient was hospitalized. Patient recovered.


Erbitux Side Effects Report #5684655-X
Erbitux side effect was reported by a Consumer or non-health professional from UNITED STATES on May 30, 2007. Female patient, 71 years of age, weighting 105.8 lb, was diagnosed with neoplasm malignant and was treated with Erbitux. After drug was administered, patient experienced the following side effects: cough, dyspnoea. Erbitux dosage: unknown. During the same period patient was treated with ZANTAC, BENADRYL, TYLENOL, MAGNESIUM SULPHATE, DETROL LA, ALPRAZOLAM, OXYCODONE, DURAGESIC. Patient recovered.

Erbitux Side Effects Report #5657249-X
Erbitux side effect was reported by a Physician from GERMANY on Mar 03, 2008. Male patient, 70 years of age, was diagnosed with neoplasm malignant and was treated with Erbitux. After drug was administered, patient experienced the following side effects: cardiac failure, dyspnoea, ischaemic stroke, oedema peripheral, renal failure acute. Erbitux dosage: unknown. During the same period patient was treated with CORDARONE, MOPRAL, KARDEGIC, TADENAN. Patient was hospitalized. Patient died on 10/29/2007.

Erbitux Side Effects Report #5678482-7
Erbitux side effect was reported by a Physician from GERMANY on Mar 17, 2008. Male patient, 70 years of age, was diagnosed with neoplasm malignant and was treated with Erbitux. After drug was administered, patient experienced the following side effects: cardiac failure, dyspnoea, ischaemic stroke, oedema peripheral, renal failure acute. Erbitux dosage: unknown. During the same period patient was treated with CORDARONE, MOPRAL, KARDEGIC, TADENAN. Patient was hospitalized. Patient died on 10/29/2007.

Erbitux Side Effects Report #5324941-6
Erbitux side effect was reported by a Pharmacist from UNITED STATES on May 10, 2007. Male patient, 68 years of age, weighting 171.0 lb, was diagnosed with neoplasm malignant and was treated with Erbitux. After drug was administered, patient experienced the following side effects: dyspnoea, pruritus, pulse absent. Erbitux dosage: 770MG ONE TIME LOAD DOSE IV DRIP. Patient recovered.

Erbitux Side Effects Report #5161296-4
Erbitux side effect was reported by a Consumer or non-health professional from UNITED STATES on Oct 13, 2006. Male patient, 65 years of age, was diagnosed with neoplasm malignant and was treated with Erbitux. After drug was administered, patient experienced the following side effects: dyspnoea. Erbitux dosage: unknown. During the same period patient was treated with BENADRYL. Patient was hospitalized. Patient recovered.

Erbitux Side Effects Report #4981714-1
Erbitux side effect was reported by a Consumer or non-health professional from UNITED STATES on Apr 18, 2006. Male patient, 64 years of age, weighting 277.8 lb, was diagnosed with neoplasm malignant and was treated with Erbitux. After drug was administered, patient experienced the following side effects: cardio-respiratory arrest, dyspnoea. Erbitux dosage: unknown. During the same period patient was treated with BENADRYL, ACTOS, LEXAPRO, PREVACID, MIRALAX, POTASSIUM CHLORIDE, ROBITUSSIN, ALBUTEROL. Patient was hospitalized. Patient recovered.

Erbitux Side Effects Report #5002238-1
Erbitux side effect was reported by a Consumer or non-health professional from UNITED STATES on Apr 18, 2006. Male patient, 64 years of age, weighting 277.8 lb, was diagnosed with neoplasm malignant and was treated with Erbitux. After drug was administered, patient experienced the following side effects: cardio-respiratory arrest, dyspnoea. Erbitux dosage: unknown. During the same period patient was treated with BENADRYL, ACTOS, LEXAPRO, PREVACID, MIRALAX, POTASSIUM CHLORIDE, ROBITUSSIN, ALBUTEROL SULPHATE. Patient was hospitalized. Patient recovered.

Erbitux Side Effects Report #5015454-X
Erbitux side effect was reported by a Consumer or non-health professional from UNITED STATES on Apr 18, 2006. Male patient, 64 years of age, weighting 277.8 lb, was diagnosed with neoplasm malignant and was treated with Erbitux. After drug was administered, patient experienced the following side effects: cardio-respiratory arrest, dyspnoea. Erbitux dosage: unknown. During the same period patient was treated with BENADRYL, ACTOS, LEXAPRO, PREVACID, MIRALAX, POTASSIUM CHLORIDE, ROBITUSSIN. Patient was hospitalized. Patient recovered.

Erbitux Side Effects Report #4780243-8
Erbitux side effect was reported by a Consumer or non-health professional from UNITED STATES on Aug 19, 2005. Male patient, 63 years of age, weighting 158.7 lb, was diagnosed with neoplasm malignant, vomiting, pollakiuria, constipation , hypercholesterolaemia, anxiety  and was treated with Erbitux. After drug was administered, patient experienced the following side effects: dyspnoea, interstitial lung disease, oxygen saturation decreased. Erbitux dosage: unknown. During the same period patient was treated with CARBOPLATIN, PACLITAXEL, COMPAZINE, FLOMAX, LACTULOSE, PRAVACHOL, WELLBUTRIN, XANAX. Patient recovered.

Erbitux Side Effects Report #5063591-6
Erbitux side effect was reported by a Pharmacist from UNITED STATES on June 09, 2006. Female patient, 62 years of age, was diagnosed with neoplasm malignant and was treated with Erbitux. After drug was administered, patient experienced the following side effects: dyspnoea, hypotension, mental impairment. Erbitux dosage: INITIAL DOSE. ADMINISTERED 13 ML=26 MG OF A TOTAL DOSE OF 688 MG.. During the same period patient was treated with BENADRYL, HYDROCORTISONE. Patient was hospitalized. Patient recovered.


Erbitux Side Effects Report #5526332-1
Erbitux side effect was reported by a Pharmacist from UNITED STATES on Nov 21, 2007. Male patient, 62 years of age, weighting 209.4 lb, was diagnosed with neoplasm malignant and was treated with Erbitux. After drug was administered, patient experienced the following side effects: dyspnoea, erythema, flushing, oxygen saturation decreased, restlessness, urticaria. Erbitux dosage: 900 MG 1X OVER 2 HOURS IV. Patient was hospitalized. Patient recovered.

Erbitux Side Effects Report #4991892-6
Erbitux side effect was reported by a Pharmacist from UNITED STATES on Mar 30, 2006. Male patient, 62 years of age, was diagnosed with neoplasm malignant and was treated with Erbitux. After drug was administered, patient experienced the following side effects: dyspnoea, flushing, hypotension, pruritus. Erbitux dosage: unknown. During the same period patient was treated with BENADRYL. Patient was hospitalized. Patient recovered.

Erbitux Side Effects Report #4610204-0
Erbitux side effect was reported by a Consumer or non-health professional from on Jan 21, 2005. Male patient, 61 years of age, was diagnosed with neoplasm malignant and was treated with Erbitux. After drug was administered, patient experienced the following side effects: blood pressure increased, cyanosis, dyspnoea. Erbitux dosage: unknown. Patient recovered.

Erbitux Side Effects Report #4996612-7
Erbitux side effect was reported by a Consumer or non-health professional from UNITED STATES on May 02, 2006. Female patient, 59 years of age, weighting 88.18 lb, was diagnosed with neoplasm malignant and was treated with Erbitux. After drug was administered, patient experienced the following side effects: cardiac failure congestive, dyspnoea, pancytopenia, venous thrombosis, wound . Erbitux dosage: INITIATED AT 400 MG IV ON 23-JAN-2006.. During the same period patient was treated with ATIVAN, AMBIEN, DEXAMETHASONE, REGULAR INSULIN, LANTUS, MIRALAX, ONDANSETRON, OXYCODONE. Patient was hospitalized. Patient recovered.

Erbitux Side Effects Report #5684814-6
Erbitux side effect was reported by a Physician from UNITED STATES on Oct 25, 2007. Female patient, 53 years of age, was diagnosed with neoplasm malignant and was treated with Erbitux. After drug was administered, patient experienced the following side effects: dyspnoea, flushing. Erbitux dosage: unknown. During the same period patient was treated with BENADRYL. Patient recovered.

Erbitux Side Effects Report #5125051-3
Erbitux side effect was reported by a Consumer or non-health professional from UNITED STATES on Oct 04, 2006. Male patient, 52 years of age, weighting 205.0 lb, was diagnosed with neoplasm malignant and was treated with Erbitux. After drug was administered, patient experienced the following side effects: blood potassium decreased, dyspnoea, hypotension, loss of consciousness. Erbitux dosage: unknown. During the same period patient was treated with DECADRON, BENADRYL, TYLENOL. Patient was hospitalized. Patient recovered.

Erbitux Side Effects Report #4962132-9
Erbitux side effect was reported by a Consumer or non-health professional from UNITED STATES on Mar 06, 2006. Male patient, 51 years of age, was diagnosed with neoplasm malignant and was treated with Erbitux. After drug was administered, patient experienced the following side effects: dyspnoea, neoplasm malignant, respiratory distress, stridor. Erbitux dosage: unknown. During the same period patient was treated with BENADRYL, CISPLATIN, TYLENOL, ANZEMET, DECADRON SRC, COUMADIN, HYCODAN. Patient was hospitalized. Patient recovered.

Erbitux Side Effects Report #5684960-7
Erbitux side effect was reported by a Consumer or non-health professional from UNITED STATES on Jan 29, 2008. Male patient, 48 years of age, was diagnosed with neoplasm malignant and was treated with Erbitux. After drug was administered, patient experienced the following side effects: blood pressure decreased, depressed level of consciousness, dyspnoea, flushing. Erbitux dosage: unknown. Patient recovered.

Erbitux Side Effects Report #5726728-9
Erbitux side effect was reported by a Physician from UNITED STATES on Apr 29, 2008. Male patient, 32 years of age, weighting 180.8 lb, was diagnosed with neoplasm malignant and was treated with Erbitux. After drug was administered, patient experienced the following side effects: anoxic encephalopathy, cardio-respiratory arrest, dyspnoea, syncope. Erbitux dosage: unknown. During the same period patient was treated with FENTANYL CITRATE, METHADONE, LORTAB. Patient was hospitalized. Patient died on 04/07/2008.

Erbitux Side Effects Report #5277224-7
Erbitux side effect was reported by a Health Professional from UNITED STATES on Mar 22, 2007. Male patient was diagnosed with neoplasm malignant and was treated with Erbitux. After drug was administered, patient experienced the following side effects: aphasia , blood pressure increased, dyspnoea, flushing, heart rate increased, infusion related reaction, oxygen saturation decreased. Erbitux dosage: 100 MG -50 CC- ONE HOUR IV DRIP. Patient recovered.


Erbitux Side Effects Report #5080405-9
Erbitux side effect was reported by a Physician from UNITED STATES on Aug 14, 2006. Female patient, weighting 120.0 lb, was diagnosed with neoplasm malignant and was treated with Erbitux. After drug was administered, patient experienced the following side effects: angina pectoris, dyspnoea, enterococcal infection, productive cough, pyrexia. Erbitux dosage: 392.5MG , WEEKLY, IV. During the same period patient was treated with PACLITAXEL, CARBOPLATIN, RADIATION. Patient was hospitalized. Patient recovered.

Erbitux Side Effects Report #4753275-3
Erbitux side effect was reported by a Consumer or non-health professional from UNITED STATES on Aug 19, 2005. Male patient was diagnosed with neoplasm malignant and was treated with Erbitux. After drug was administered, patient experienced the following side effects: dyspnoea, oxygen saturation decreased. Erbitux dosage: SECOND DOSE OF 250 MG/M2 ADMINISTERED ON 10-AUG-2005. ERBITUX INTERRUPTED (DATE NOT REPORTED).. During the same period patient was treated with CARBOPLATIN, PACLITAXEL. Patient recovered.

Erbitux Side Effects Report #5005809-1
Erbitux side effect was reported by a Pharmacist from UNITED STATES on May 17, 2006. Female patient was diagnosed with neoplasm malignant and was treated with Erbitux. After drug was administered, patient experienced the following side effects: dyspnoea, hypotension, mental status changes. Erbitux dosage: 26MG X 1 IV. Patient was hospitalized. Patient recovered.

Erbitux Side Effects Report #5109370-2
Erbitux side effect was reported by a Consumer or non-health professional from UNITED STATES on Nov 28, 2005. Male patient, 17 years of age, was diagnosed with neoplasm and was treated with Erbitux. After drug was administered, patient experienced the following side effects: abdominal distension, abdominal infection, colitis, dehydration, diarrhoea, dyspnoea, fatigue, febrile neutropenia, hallucination. Erbitux dosage: unknown. During the same period patient was treated with IRINOTECAN, MEGACE, NEURONTIN, BACTRIM, PERCOCET, MIRALAX, PAXIL. Patient was hospitalized. Patient recovered.

Erbitux Side Effects Report #5008886-7
Erbitux side effect was reported by a Consumer or non-health professional from UNITED STATES on Nov 28, 2005. Male patient, 17 years of age, was diagnosed with neoplasm and was treated with Erbitux. After drug was administered, patient experienced the following side effects: abdominal distension, colitis, dehydration, diarrhoea, dyspnoea, fatigue, febrile neutropenia, hyponatraemia, ileus. Erbitux dosage: unknown. During the same period patient was treated with IRINOTECAN, MEGACE, NEURONTIN, BACTRIM, PERCOCET, MIRALAX, PAXIL. Patient was hospitalized. Patient recovered.

Erbitux Side Effects Report #5051876-9
Erbitux side effect was reported by a Pharmacist from UNITED STATES on July 13, 2006. Female patient, 56 years of age, weighting 143.5 lb, was diagnosed with lung neoplasm malignant and was treated with Erbitux. After drug was administered, patient experienced the following side effects: bradycardia, cardiac arrest , cardiac disorder, cardiomyopathy , dyspnoea, hyperhidrosis, hypotension, infusion related reaction, ventricular fibrillation. Erbitux dosage: 430 MG IV X 1 (DOSED 250MG/M2). Patient was hospitalized. Patient recovered.

Erbitux Side Effects Report #6131497-7
Erbitux side effect was reported by a Consumer or non-health professional from UNITED STATES on Nov 03, 2008. Male patient, 53 years of age, was diagnosed with lung neoplasm malignant and was treated with Erbitux. After drug was administered, patient experienced the following side effects: dyspnoea, feeling cold, oxygen saturation decreased, tachycardia, tremor, wheezing. Erbitux dosage: unknown. During the same period patient was treated with HYDROCODONE BITARTRATE, ADVAIR HFA, ASPIRIN, MUCINEX, DEXAMETHASONE, FOLIC ACID, SPIRIVA, AMIODARONE. Patient was hospitalized. Patient recovered.

Erbitux Side Effects Report #5485560-4
Erbitux side effect was reported by a Health Professional from UNITED STATES on Oct 11, 2007. Female patient, weighting 204.0 lb, was diagnosed with lung neoplasm malignant and was treated with Erbitux. After drug was administered, patient experienced the following side effects: clostridium difficile colitis, cough, dyspnoea, dyspnoea exertional, heart rate increased, pneumonia , pulmonary embolism , respiratory rate increased. Erbitux dosage: 250MG/M2 (500MG) WEEKLY IV. Patient was hospitalized. Patient recovered.

Erbitux Side Effects Report #6111548-6
Erbitux side effect was reported by a Health Professional from UNITED STATES on Mar 10, 2009. Male patient, weighting 214.0 lb, was diagnosed with lung neoplasm malignant and was treated with Erbitux. After drug was administered, patient experienced the following side effects: atrial flutter, cough, dyspnoea, left atrial dilatation, left ventricular hypertrophy, pulmonary hypertension , rhonchi, supraventricular tachycardia. Erbitux dosage: 540 MG QW IV DRIP. Patient was hospitalized. Patient recovered.

Erbitux Side Effects Report #5677433-9
Erbitux side effect was reported by a Health Professional from GERMANY on Mar 19, 2008. Male patient, 74 years of age, was diagnosed with lip and/or oral cavity cancer and was treated with Erbitux. After drug was administered, patient experienced the following side effects: chronic obstructive pulmonary disease, dyspnoea, pneumonia aspiration. Erbitux dosage: STRENGTH- 2MG/ML.. Patient recovered.

Erbitux Side Effects Report #5680576-7
Erbitux side effect was reported by a Health Professional from GERMANY on Mar 21, 2008. Male patient, 74 years of age, was diagnosed with lip and/or oral cavity cancer and was treated with Erbitux. After drug was administered, patient experienced the following side effects: dyspnoea. Erbitux dosage: STRENGTH- 2MG/ML.. Patient recovered.

Erbitux Side Effects Report #5856366-9
Erbitux side effect was reported by a Health Professional from GERMANY on Aug 21, 2008. Male patient, 74 years of age, was diagnosed with lip and/or oral cavity cancer and was treated with Erbitux. After drug was administered, patient experienced the following side effects: dyspnoea. Erbitux dosage: STRENGTH- 2MG/ML.. Patient recovered.

Erbitux Side Effects Report #6131488-6
Erbitux side effect was reported by a Consumer or non-health professional from UNITED STATES on Sept 22, 2008. Male patient, 70 years of age, was diagnosed with laryngeal cancer stage iii and was treated with Erbitux. After drug was administered, patient experienced the following side effects: blood pressure increased, chest pain , dyspnoea, rash , urticaria. Erbitux dosage: 400MG/M 2. Patient recovered.

Erbitux Side Effects Report #5225761-3
Erbitux side effect was reported by a Pharmacist from UNITED STATES on Jan 31, 2007. Male patient, 62 years of age, weighting 172.0 lb, was diagnosed with laryngeal cancer and was treated with Erbitux. After drug was administered, patient experienced the following side effects: chest pain , cold sweat, dyspnoea, feeling cold, hyperhidrosis. Erbitux dosage: 800MG OVER TWO HOURS IV DRIP. During the same period patient was treated with BENADRYL. Patient recovered.

Erbitux Side Effects Report #5591114-1
Erbitux side effect was reported by a Pharmacist from UNITED STATES on Jan 11, 2008. Male patient, weighting 177.9 lb, was diagnosed with hypopharyngeal cancer and was treated with Erbitux. After drug was administered, patient experienced the following side effects: blood pressure increased, dyspnoea. Erbitux dosage: 760MG IV 2 HOUR INFUSION. Patient was hospitalized. Patient recovered.

Erbitux Side Effects Report #4638829-7
Erbitux side effect was reported by a Pharmacist from on Apr 18, 2005. Female patient, 79 years of age, weighting 76.94 lb, was diagnosed with hepatic neoplasm malignant, metastasis and was treated with Erbitux. After drug was administered, patient experienced the following side effects: blood pressure decreased, depressed level of consciousness, dyspnoea, hyperhidrosis, prolonged expiration, respiratory rate increased, staring, wheezing. Erbitux dosage: 760MG ONE-TIME DOSE INTRAVENOUS. During the same period patient was treated with PAXIL, NYSTATIN TOPICAL, METOPROLOL TARTRATE, METOCLOPRAMIDE, MAGOX, HUMULIN R. Patient recovered.

Erbitux Side Effects Report #5684725-6
Erbitux side effect was reported by a Health Professional from UNITED STATES on Aug 31, 2007. Male patient, 60 years of age, was diagnosed with hepatic cancer metastatic and was treated with Erbitux. After drug was administered, patient experienced the following side effects: chest discomfort, chills, dyspnoea, hypertension, infusion related reaction, nausea . Erbitux dosage: unknown. During the same period patient was treated with BENADRYL, DECADRON. Patient was hospitalized. Patient recovered.

Erbitux Side Effects Report #5963809-9
Erbitux side effect was reported by a Health Professional from UNITED STATES on Nov 19, 2008. Male patient, 60 years of age, was diagnosed with head and neck cancer , nausea  and was treated with Erbitux. After drug was administered, patient experienced the following side effects: aspiration, dyspnoea, vomiting. Erbitux dosage: INITIATED ON 15SEP08:844MG. During the same period patient was treated with CARBOPLATIN, ABRAXANE, ATIVAN, DECADRON, DIFLUCAN, FENTANYL, FLONASE, LACTULOSE. Patient was hospitalized. Patient recovered.

Erbitux Side Effects Report #6015980-0
Erbitux side effect was reported by a Health Professional from UNITED STATES on Dec 19, 2008. Male patient, 60 years of age, was diagnosed with head and neck cancer , nausea  and was treated with Erbitux. After drug was administered, patient experienced the following side effects: aspiration, dyspnoea, vomiting. Erbitux dosage: INITIATED ON 15SEP08:844MG. During the same period patient was treated with CARBOPLATIN, ABRAXANE, ATIVAN, DECADRON, DIFLUCAN, FENTANYL, FLONASE, LACTULOSE. Patient was hospitalized. Patient recovered.

Erbitux Side Effects Report #6131367-4
Erbitux side effect was reported by a Pharmacist from UNITED STATES on May 15, 2008. Male patient, 53 years of age, was diagnosed with head and neck cancer  and was treated with Erbitux. After drug was administered, patient experienced the following side effects: aphasia , dyspnoea, hot flush, laryngeal oedema, pruritus. Erbitux dosage: FIRST TIME LOADING DOSE OF 400 MG/M2.. During the same period patient was treated with BENADRYL. Patient recovered.

Erbitux Side Effects Report #5796139-9
Erbitux side effect was reported by a Physician from UNITED STATES on June 27, 2008. Male patient, 32 years of age, weighting 180.8 lb, was diagnosed with head and neck cancer , pain prophylaxis and was treated with Erbitux. After drug was administered, patient experienced the following side effects: anoxic encephalopathy, cardio-respiratory arrest, dyspnoea, syncope. Erbitux dosage: unknown. During the same period patient was treated with METHADON, LORTAB, DURAGESIC. Patient was hospitalized. Patient died on 04/07/2008.